Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen TEPI Patch Irritation and Adhesion Study
NCT03639571Phase 1Completed
- Sponsor
- Medherant
- Start
- Aug 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pain comparing Ibuprofen TEPI Patch with Placebo TEPI Patch (2 arms). Primary endpoints: Mean Irritation Score at 10 days and Total Cumulative Irritation Score at 10 days. Started Aug 2018; status: completed.
02
Drugs
ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT03639571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03639571.